Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001255294-12-000249
Filing Date
2012-04-20
Accepted
2012-04-20 17:29:48
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-K 1359678
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8023
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8005
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4485
5 GRAPHIC image_001.jpg GRAPHIC 5418
  Complete submission text file 0001255294-12-000249.txt   3618411

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ambs-20111231.xml EX-101.INS 473673
7 XBRL SCHEMA FILE ambs-20111231.xsd EX-101.SCH 19185
8 XBRL DEFINITION FILE ambs-20111231_def.xml EX-101.DEF 23563
9 XBRL LABEL FILE ambs-20111231_lab.xml EX-101.LAB 105072
10 XBRL PRESENTATION FILE ambs-20111231_pre.xml EX-101.PRE 79943
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus BioSciences, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-148922 | Film No.: 12771635
SIC: 2834 Pharmaceutical Preparations